Testing effectiveness (Phase 2)Not Yet RecruitingNCT07236463
What this trial is testing
Labile Iron Removal by Adding the Iron Chelator MEX-CD1 to Dialysate in Sepsis-Associated Acute Kidney Injury
Who this might be right for
Acute Kidney InjurySepsis
Centre Hospitalier Universitaire de Nīmes 14